直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Laura P. Masurovsky

Eric Raciti and Aaron Capron on Medical Device Patents

October 6, 2014

By Eric P. Raciti; Aaron J. Capron

Medical device manufacturers are faced with unique intellectual property challenges. Manufacturers can spend years bringing a medical device to market and often rely on investors for commercialization. Potential investors carefully examine device makers' patent portfolios to ensure their intellectual property is in good order before making significant financial decisions. Eric P. Raciti and Aaron J. Capron discuss the importance of patents for medical device manufacturers and the steps they can take to enhance their marketability.

Downloadable Files

  • MedicalDevices

Related Practices

智財權申請及組合管理

IP Portfolio Management

Related Industries

生命科學

醫療器材和診斷

Related Offices

Boston, MA

Palo Alto, CA

Related Professionals

Eric P. Raciti
Partner
Boston, MA
+1 617 646 1675
Email
Aaron J. Capron
Partner
Palo Alto, CA
+1 650 849 6680
Email

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Seminar

The Augmented Practice 2026: Balancing AI Opportunity, Governance, and Risk

November 5, 2026

San Francisco

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

2026 Patent Law Institute: Critical Issues & Best Practices – New York

October 29, 2026

New York

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Federal Circuit IP Blog

Federal Circuit Affirms PTAB Obviousness Finding in DRAM Data Path Patent

October 5, 2026

Federal Circuit IP Blog

Federal Circuit Distinguishes Patent Eligibility Among Different Communications Systems Claims

October 5, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP